Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis: The PEPsCog Study

Schizophrenia Research

Volumn 164, Issue 1-3, 2015, Pages 65-73

  Cuesta, Manuel J ^a,b   Sánchez Torres, Ana M ^a,b   Cabrera, Bibiana ^c,e   Bioque, Miquel ^c,e   Merchán Naranjo, Jessica ^e,f   Corripio, Iluminada ^e,g   González Pinto, Ana ^e,h   Lobo, Antonio ^e,i   Bombín, Igor ^e,j   de la Serna, Elena ^c,e   Sanjuan, Julio ^e,k   Parellada, Mara ^e,f   Saiz Ruiz, Jerónimo ^e,l   Bernardo, Miquel ^c,d,e   Mezquida, Gisela ^c   Penadés, Rafael ^c   Calvo, Ana ^e,f   Arango, Celso ^e,f   Alonso Solís, Anna ^g   Grasa, Eva M ^g   de Azua, Sonia Ruiz ^h   Barbeito, Sara ^h   Gutiérrez Galve, Leticia ⁱ   Barconesi, Fe ⁱ   Aguilar, Eduardo J ^e,k   Bergé, Daniel ^u   Cortizo, Romina ^u   Torrent, Carla ^d   Vieta, Eduard ^d   Baeza, Immaculada ^c   Castro Fornieles, Josefina ^c   Contreras, Fernando ^d,e,m   Albacete, àuria ^d,m   Al Halabí, Susana ^e   Bobes, Julio ^e,n   Zabala, Arantzazu ^e,o,p   Rodriguez Jimenez, Roberto ^e,q   Usall, Judith ^e,r   Sarró, Salvador ^e,s   Ibáñez, ángela ^e,l   Moreno Izco, Lucía ^a,b   Balanzá Martínez, Vicent ^e,t   more..

^a Universidad Pública de Navarra   (Spain)

^b Recinto de Complejo Hospitalario de Navarra   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^f UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h HOSPITAL TXAGORRITXU   (Spain)

ⁱ INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN IIS ARAGÓN   (Spain)

^j Reintegra Foundation   (Spain)

^k Instituto Universitario IVI INCLIVA   (Spain)

^l UNIVERSITY OF ALCALÁ   (Spain)

^m HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁿ UNIVERSITY OF OVIEDO   (Spain)

^o UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^p BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

^q HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^r PARC SANITARI SANT JOAN DE DÉU   (Spain)

^s FIDMAG GERMANES HOSPITALÀRIES RESEARCH FOUNDATION   (Spain)

^t UNIVERSITY OF VALENCIA   (Spain)

^u Institut de Neuropsiquiatria i Addiccions   (Spain)

more..

Author keywords

Cognition; First episode psychosis; Premorbid adjustment; Schizophrenia spectrum disorders

Indexed keywords

NEUROLEPTIC AGENT;

ADJUSTMENT; ADULT; AGE; ARTICLE; ATTENTION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BRIEF PSYCHOTIC DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSIVE PSYCHOSIS; DOSE RESPONSE; EXECUTIVE FUNCTION; FEMALE; GENDER; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MANIC PSYCHOSIS; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SOCIAL COGNITION; SOCIAL STATUS; VERBAL MEMORY; WORKING MEMORY; YOUNG ADULT; ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; COGNITION DISORDERS; COMPLICATION; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS; STATISTICS;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHILD; COGNITION DISORDERS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84929261785     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.02.022     Document Type: Article

References (93)

1. Aas M., Dazzan P., Mondelli V., Melle I., Murray R.M., Pariante C.M. A systematic review of cognitive function in first-episode psychosis, including a discussion on childhood trauma, stress, and inflammation. Front. Psychol. 2014, 4:182.
2. Addington J., Addington D. Patterns of premorbid functioning in first episode psychosis: relationship to 2-year outcome. Acta Psychiatr. Scand. 2005, 112(1):40-46.
3. Addington J., van Mastrigt S., Addington D. Patterns of premorbid functioning in first-episode psychosis: initial presentation. Schizophr. Res. 2003, 62(1-2):23-30.
4. Albus M., Hubmann W., Mohr F., Scherer J., Sobizack N., Franz U., Hecht S., Borrmann M., Wahlheim C. Are there gender differences in neuropsychological performance in patients with first-episode schizophrenia?. Schizophr. Res. 1997, 28(1):39-50.
5. Allen D.N., Frantom L.V., Strauss G.P., van Kammen D.P. Differential patterns of premorbid academic and social deterioration in patients with schizophrenia. Schizophr. Res. 2005, 75(2-3):389-397.
6. American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 1994, American Psychiatric Association, Washington.
7. Amini H., Alaghband-rad J., Omid A., Sharifi V., Davari-Ashtiani R., Momeni F., Aminipour Z. Diagnostic stability in patients with first-episode psychosis. Australas. Psychiatry 2005, 13(4):388-392.
8. Ayesa-Arriola R., Rodriguez-Sanchez J.M., Gomez-Ruiz E., Roiz-Santiañez R., Reeves L.L., Crespo-Facorro B. No sex differences in neuropsychological performance in first episode psychosis patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 48:149-154.
9. Barnett J.H., Salmond C.H., Jones P.B., Sahakian B.J. Cognitive reserve in neuropsychiatry. Psychol. Med. 2006, 36(8):1053-1064.
10. Benedet M.J., Alejandre M.A. Test de Aprendizaje Verbal España-Complutense 1998, TEA Ediciones, Madrid.
11. Bernardo M., Bioque M., Parellada M., Saiz Ruiz J., Cuesta M.J., Llerena A., Sanjuan J., Castro-Fornieles J., Arango C., Cabrera B. Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs). Rev. Psiquiatr. Salud Ment. 2013, 6(1):4-16.
12. Bilder R.M., Lipschutz-Broch L., Reiter G., Geisler S.H., Mayerhoff D.I., Lieberman J.A. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr. Bull. 1992, 18(3):437-448.
13. Bilder R.M., Goldman R.S., Robinson D., Reiter G., Bell L., Bates J.A., Pappadopulos E., Willson D.F., Alvir J.M., Woerner M.G., Geisler S., Kane J.M., Lieberman J.A. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am. J. Psychiatry 2000, 157(4):549-559.
14. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8(3):470-484.
15. Chang W.C., Yee Man Tang J., Lai Ming Hui C., Hoi Yan Wong G., Kit Wa Chan S., Ho Ming Lee E., Yu Hai Chen E. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study. Psychiatry Res. 2013, 209(3):353-360.
16. Conners C.K. Continuous Performance Test-II 2000, MHS, Toronto.
17. Cornblatt B., Obuchowski M., Schnur D.B., O'Brien J.D. Attention and clinical symptoms in schizophrenia. Psychiatr. Q. 1997, 68(4):343-359.
18. Crespo-Facorro B., Rodriguez-Sanchez J.M., Perez-Iglesias R., Mata I., Ayesa R., Ramirez-Bonilla M., Martinez-Garcia O., Vazquez-Barquero J.L. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. J. Clin. Psychiatry 2009, 70(5):717-729.
19. Cuesta M.J., Peralta V. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Res. 1995, 58(3):227-235.
20. Davidson M., Galderisi S., Weiser M., Werbeloff N., Fleischhacker W.W., Keefe R.S., Boter H., Keet I.P., Prelipceanu D., Rybakowski J.K., Libiger J., Hummer M., Dollfus S., Lopez-Ibor J.J., Hranov L.G., Gaebel W., Peuskens J., Lindefors N., Riecher-Rossler A., Kahn R.S. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am. J. Psychiatry 2009, 166(6):675-682.
21. First M., Gibbon M., Spitzer R.L. Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II) 1997, American Psychiatric Press, Washington, DC.
22. First M., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) 1997, American Psychiatric Press, Washington, DC.
23. Flashman L.A., Green M.F. Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment. Psychiatr. Clin. N. Am. 2004, 27(1):1-18. (vii).
24. Galderisi S., Davidson M., Kahn R.S., Mucci A., Boter H., Gheorghe M.D., Rybakowski J.K., Libiger J., Dollfus S., Lopez-Ibor J.J., Peuskens J., Hranov L.G., Fleischhacker W.W. Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr. Res. 2009, 115(2-3):104-114.
25. Gardner D.M., Murphy A.L., O'Donnell H., Centorrino F., Baldessarini R.J. International consensus study of antipsychotic dosing. Am. J. Psychiatry 2010, 167(6):686-693.
26. Gilvarry C., Takei N., Russell A., Rushe T., Hemsley D., Murray R.M. Premorbid IQ in patients with functional psychosis and their first-degree relatives. Schizophr. Res. 2000, 41(3):417-429.
27. Goldberg T.E., Keefe R.S., Goldman R.S., Robinson D.G., Harvey P.D. Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. Neuropsychopharmacology 2010, 35(5):1053-1062.
28. Goldberg S., Fruchter E., Davidson M., Reichenberg A., Yoffe R., Weiser M. The relationship between risk of hospitalization for schizophrenia, SES, and cognitive functioning. Schizophr. Bull. 2011, 37(4):664-670.
29. Golden C.J. Stroop Color and Word Test. A Manual for Clinical and Experimental Uses 1978, Stoelting Co., Wood Dale, Illinois.
30. Green M.F., Nuechterlein K.H. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr. Res. 2004, 72(1):1-3.
31. Green M.F., Nuechterlein K.H., Gold J.M., Barch D.M., Cohen J., Essock S., Fenton W.S., Frese F., Goldberg T.E., Heaton R.K., Keefe R.S., Kern R.S., Kraemer H., Stover E., Weinberger D.R., Zalcman S., Marder S.R. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol. Psychiatry 2004, 56(5):301-307.
32. Hafner H., an der Heiden W. Epidemiology of schizophrenia. Can. J. Psychiatry 1997, 42(2):139-151.
33. Heaton R., Chelune G., Talley J., Kay G., Curtiss G. Wisconsin Card Sorting Test 1993, Psychological Assessment Resources, Odessa, FL.
34. Heinrichs R., Zakzanis K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12:426-445.
35. Heydebrand G., Weiser M., Rabinowitz J., Hoff A.L., DeLisi L.E., Csernansky J.G. Correlates of cognitive deficits in first episode schizophrenia. Schizophr. Res. 2004, 68(1):1-9.
36. Hoff A.L., Wieneke M., Faustman W.O., Horon R., Sakuma M., Blankfeld H., Espinoza S., DeLisi L.E. Sex differences in neuropsychological functioning of first-episode and chronically ill schizophrenic patients. Am. J. Psychiatry 1998, 155(10):1437-1439.
37. Hollingshead A.B., Redlich F.C. Class and Mental Illness 1958, Wiley, New York.
38. Howes O.D., Fusar-Poli P., Bloomfield M., Selvaraj S., McGuire P. From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments. Curr. Pharm. Des. 2012, 18(4):459-465.
39. IBM Corp Released 2011. IBM SPSS Statistics for Windows, Version 20.0 2011, IBM Corp., Armonk, NY.
40. Jefferson A.L., Gibbons L.E., Rentz D.M., Carvalho J.O., Manly J., Bennett D.A., Jones R.N. A life course model of cognitive activities, socioeconomic status, education, reading ability, and cognition. J. Am. Geriatr. Soc. 2011, 59(8):1403-1411.
41. Joyce E.M., Hutton S.B., Mutsatsa S.H., Barnes T.R. Cognitive heterogeneity in first-episode schizophrenia. Br. J. Psychiatry 2005, 187:516-522.
42. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
43. Keefe R.S., Fenton W.S. How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophr. Bull. 2007, 33(4):912-920.
44. Koenen K.C., Moffitt T.E., Roberts A.L., Martin L.T., Kubzansky L., Harrington H., Poulton R., Caspi A. Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. Am. J. Psychiatry 2009, 166(1):50-57.
45. Komuravelli A., Poole R., Higgo R. Stability of the diagnosis of first-episode drug-induced psychosis. Psychiatrist 2011, 35:224-227.
46. Larsen T.K., Friis S., Haahr U., Johannessen J.O., Melle I., Opjordsmoen S., Rund B.R., Simonsen E., Vaglum P.V., McGlashan T.H. Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course. Br. J. Psychiatry 2004, 185:108-115.
47. Leeson V.C., Barnes T.R., Hutton S.B., Ron M.A., Joyce E.M. IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis. Schizophr. Res. 2009, 107(1):55-60.
48. Leeson V.C., Barnes T.R., Harrison M., Matheson E., Harrison I., Mutsatsa S.H., Ron M.A., Joyce E.M. The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophr. Bull. 2010, 36(2):400-409.
49. Lencz T., Smith C.W., McLaughlin D., Auther A., Nakayama E., Hovey L., Cornblatt B.A. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol. Psychiatry 2006, 59(9):863-871.
50. Levy E., Pawliuk N., Joober R., Abadi S., Malla A. Medication-adherent first-episode psychosis patients also relapse: why?. Can. J. Psychiatry 2012, 57(2):78-84.
51. Lewine R. At issue: sex and gender in schizophrenia. Schizophr. Bull. 2004, 30(4):755-762.
52. Lewine R.R., Walker E.F., Shurett R., Caudle J., Haden C. Sex differences in neuropsychological functioning among schizophrenic patients. Am. J. Psychiatry 1996, 153(9):1178-1184.
53. Liddle P.F. Syndromes in schizophrenia and their neuropsychological and neuroanatomical correlates. Schizophrenia: A Neuropsychological Perspective 1996, 299-316. John Wiley, Chicester. C. Pantelis, H.E. Nelson, T.R.E. Barnes (Eds.).
54. Little R.J.A. A test of missing completely at random for multivariate data with missing values. J. Am. Stat. Assoc. 1998, 83:1198-1202.
55. Lobo A., Chamorro L., Luque A., Dal-Re R., Badia X., Baro E. Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales. Med. Clin. (Barc.) 2002, 118(13):493-499.
56. Loonstra A.S., Tarlow A.R., Sellers A.H. COWAT metanorms across age, education, and gender. Appl. Neuropsychol. 2001, 8(3):161-166.
57. Lucas S., Redoblado-Hodge M.A., Shores A., Brennan J., Harris A. Predictors of outcome three years after diagnosis of first episode psychosis. Psychiatry Res. 2008, 161(1):11-18.
58. Martin L.T., Kubzansky L.D., LeWinn K.Z., Lipsitt L.P., Satz P., Buka S.L. Childhood cognitive performance and risk of generalized anxiety disorder. Int. J. Epidemiol. 2007, 36(4):769-775.
59. Mayer J.D., Salovey P., Caruso D.R. Mayer-Salovey-Caruso Emotional Intelligence Test (Spanish version) 2009, TEA Ediciones, Madrid.
60. McGlashan T.H. Premorbid adjustment, onset types, and prognostic scaling: still informative?. Schizophr. Bull. 2008, 34(5):801-805.
61. Mesholam-Gately R.I., Giuliano A.J., Goff K.P., Faraone S.V., Seidman L.J. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009, 23(3):315-336.
62. Meyer U. Developmental neuroinflammation and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:20-34.
63. Mohamed S., Paulsen J.S., O'Leary D., Arndt S., Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch. Gen. Psychiatry 1999, 56(8):749-754.
64. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
65. Nieuwenstein M.R., Aleman A., de Haan E.H.F. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. J. Psychiatr. Res. 2001, 35(2):119-125.
66. Norman R.M., Malla A.K., Manchanda R., Townsend L. Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains. Acta Psychiatr. Scand. 2005, 112(1):30-39.
67. Nuechterlein K.H., Green M.F. MCCB: Matrics Consensus Cognitive Battery 2006, Matrics Assessment, Los Angeles.
68. O'Connor J.A., Wiffen B.D., Reichenberg A., Aas M., Falcone M.A., Russo M., Sood P.G., Taylor H., David A.S. Is deterioration of IQ a feature of first episode psychosis and how can we measure it?. Schizophr. Res. 2012, 137(1-3):104-109.
69. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9(1):97-113.
70. Owens S.F., Picchioni M.M., Rijsdijk F.V., Stahl D., Vassos E., Rodger A.K., Collier D.A., Murray R.M., Toulopoulou T. Genetic overlap between episodic memory deficits and schizophrenia: results from the Maudsley Twin Study. Psychol. Med. 2011, 41(3):521-532.
71. Peña-Casanova J. Test Barcelona 1990, Masson, Barcelona.
72. Peralta V., Cuesta M.J. Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia. Psychiatry Res. 1994, 53(1):31-40.
73. Reichenberg A., Harvey P.D. Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychol. Bull. 2007, 133(5):833-858.
74. Reichenberg A., Harvey P.D., Bowie C.R., Mojtabai R., Rabinowitz J., Heaton R.K., Bromet E. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr. Bull. 2009, 35(5):1022-1029.
75. Reitan R., Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation 1993, Neuropsychology Press, Tucson, AZ.
76. Ruggero C.J., Carlson G.A., Kotov R., Bromet E.J. Ten-year diagnostic consistency of bipolar disorder in a first-admission sample. Bipolar Disord. 2010, 12(1):21-31.
77. Rund B.R., Melle I., Friis S., Larsen T.K., Midboe L.J., Opjordsmoen S., Simonsen E., Vaglum P., McGlashan T. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am. J. Psychiatry 2004, 161(3):466-472.
78. Rund B.R., Melle I., Friis S., Johannessen J.O., Larsen T.K., Midbøe L.J., Opjordsmoen S., Simonsen E., Vaglum P., McGlashan T. The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse. Schizophr. Res. 2007, 91(1-3):132-140.
79. Schimmelmann B.G., Conus P., Edwards J., McGorry P.D., Lambert M. Diagnostic stability 18months after treatment initiation for first-episode psychosis. J. Clin. Psychiatry 2005, 66(10):1239-1246.
80. Schretlen D.J., Cascella N.G., Meyer S.M., Kingery L.R., Testa S.M., Munro C.A., Pulver A.E., Rivkin P., Rao V.A., Diaz-Asper C.M., Dickerson F.B., Yolken R.H., Pearlson G.D. Neuropsychological functioning in bipolar disorder and schizophrenia. Biol. Psychiatry 2007, 62(2):179-186.
81. Schwartz J.E., Fennig S., Tanenberg-Karant M., Carlson G., Craig T., Galambos N., Lavelle J., Bromet E.J. Congruence of diagnoses 2years after a first-admission diagnosis of psychosis. Arch. Gen. Psychiatry 2000, 57(6):593-600.
82. Seidman L.J., Kremen W.S., Koren D., Faraone S.V., Goldstein J.M., Tsuang M.T. A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophr. Res. 2002, 53(1-2):31-44.
83. Seidman L.J., Giuliano A.J., Meyer E.C., Addington J., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Christensen B.K., Hawkins K., Heaton R., Keefe R.S., Heinssen R., Cornblatt B.A. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch. Gen. Psychiatry 2010, 67(6):578-588.
84. Silverstein M.L., Mavrolefteros G., Close D. Premorbid adjustment and neuropsychological performance in schizophrenia. Schizophr. Bull. 2002, 28(1):157-165.
85. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J. Int. Neuropsychol. Soc. 2002, 8(3):448-460.
86. Toulopoulou T., Quraishi S., McDonald C., Murray R.M. The Maudsley Family Study: premorbid and current general intellectual function levels in familial bipolar I disorder and schizophrenia. J. Clin. Exp. Neuropsychol. 2006, 28(2):243-259.
87. Townsend L.A., Malla A.K., Norman R.M. Cognitive functioning in stabilized first-episode psychosis patients. Psychiatry Res. 2001, 104(2):119-131.
88. van Winkel R., Myin-Germeys I., Delespaul P., Peuskens J., De Hert M., van Os J. Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: a 10-year follow-up study. Schizophr. Res. 2006, 88(1-3):47-54.
89. Wechsler D. Wechsler Adult Intelligence Scale III 1999, TEA ediciones, Madrid.
90. Whitty P., Clarke M., McTigue O., Browne S., Kamali M., Larkin C., O'Callaghan E. Diagnostic stability four years after a first episode of psychosis. Psychiatr. Serv. 2005, 56(9):1084-1088.
91. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.
92. Zammit S., Allebeck P., David A.S., Dalman C., Hemmingsson T., Lundberg I., Lewis G. A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch. Gen. Psychiatry 2004, 61(4):354-360.
93. Zanelli J., Reichenberg A., Morgan K., Fearon P., Kravariti E., Dazzan P., Morgan C., Zanelli C., Demjaha A., Jones P.B., Doody G.A., Kapur S., Murray R.M. Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am. J. Psychiatry 2010, 167(1):78-85.